Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

Joshua J. Solomon, Marilyn K. Glassberg, Isabel Amigues et al.|The Lancet Respiratory Medicine|2022

Cited by 211